MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Implementation of a mobile application in the Luxembourg Parkinson’s study for identification and validation of disease stage and variation

    R. Krüger, G. Hipp, M. Kerschenmeyer, P.L. Kolber, A. Trister, C. Suver, V.P. Satagopam, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Balling, S. Friend (Belvaux, Luxembourg)

    Objective: The project focuses on integrating a mobile application (mPower) into the Luxembourg Parkinson's cohort (HELP-PD) to monitor frequency and degree of variation in symptoms…
  • 2016 International Congress

    Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities

    V. Chelban, A. Tucci, H. Houlden (Chisinau, Republic of Moldova)

    Objective: To (1) describe the genetic variability, phenotype and epidemiology of spastin mutation in HSP patients (2) create the UK HSP register with a focus…
  • 2016 International Congress

    Genetic analysis of eighty-seven multiple system atrophy patients

    G. Franco, D. Ronchi, I. Trezzi, L. Borellini, F. Del Sorbo, B. Garavaglia, A.E. Elia, G. Ardolino, G. Mora, S. Bonato, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)

    Objective: To analyze candidate genes in a cohort of 87 patients with a clinical diagnosis of probable MSA. Background: Multiple System Atrophy (MSA) is a…
  • 2016 International Congress

    Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?

    A. Khlebtovsky, R. Dabby, Y. Rodity, I. Steiner, R. Djaldetti (Petach Tikva, Israel)

    Objective: To examine whether there is a connection between clinical findings, genetics and QST data of Parkinson's disease(PD) patients and to characterize the genetic mechanisms…
  • 2016 International Congress

    Hereditary atypical parkinsonism with novel mutation of the VPS35 and FBXO7 genes

    K. Mensikova, T. Bartonikova, L. Mikulicova, R. Vodicka, R. Vrtel, M. Godava, I. Dolinova, M. Vastik, M. Kaiserova, P. Otruba, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To determine the genetic background of hereditary atypical parkinsonism in an isolated region of the Czech Republic. Background: A higher prevalence of parkinsonism was…
  • 2016 International Congress

    C9ORF72 intermediate repeat copies as a rare genetic cause of atypical Parkinsonian syndromes or Parkinson’s disease complicated by psychosis in a Sardinian population

    M. Meloni, A. Cannas, P. Solla, M.M. Mascia, G. Orofino, R. Farris, D. Ciaccio, E. Binaghi, M.R. Murru, F. Marrosu (Cagliari, Italy)

    Objective: To screen for the presence of C9ORF72 repeat expansions in patients affected by atypical parkinsonism syndromes and PD complicated by psychosis or dementia, and…
  • 2016 International Congress

    Coding and non-coding glucocerebrosidase variants have an impact on cognitive decline in Parkinson’s disease

    C. Schulte, I. Liepelt-Scarfone, C.E. Hagen, A.K. Hauser, K. Brockmann, T. Gasser, J.B. Schulz, K. Reetz, S. Gräber, B. Mollenhauer, C. Trenkwalder, K. Witt, N. Schmidt, R. Dodel, M. Balzer-Geldsetzer, U. Wüllner, T. Klockgether, A. Spottke, A. Storch, H.U. Wittchen, O. Riedel, S. Baudrexel, E. Kalbe, D. Berg, M.M. Mielke (Tübingen, Germany)

    Objective: To evaluate the impact of genetic variants in the Glucocerebrosidase gene (GBA) on cognitive impairment in a large cohort of Parkinson's disease (PD) patients…
  • 2016 International Congress

    Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency

    M. Quadri, M. Skorvanek, S. Olgiati, M. Minneboo, J. Graafland, G.J. Breedveld, R. Bonte, Z. Ozgur, K. Schoonderwoerd, F.W. Verheijen, W.F.J. van Ijcken, H. Fen Chien, E. Reis Barbosa, H.C. Chang, S.C. Lai, T.H. Yeh, C.S. Lu, Y.H. Wu-Chou, A.J.A. Kievit, V. Han, Z. Gdovinova, R. Jech, R.M.W. Hofstra, G.J.G. Ruijter, W. Mandemakers, V. Bonifati (Rotterdam, Netherlands)

    Objective: To describe a family with two siblings affected by different dystonic disorders as a resulting phenotype of ECHS1 mutations. Background: ECHS1 encodes a mitochondrial…
  • 2016 International Congress

    Generation of human induced pluripotent stem cells carrying a safety bet for cell-based therapy in Parkinson’s disease

    Y. Kimura, Y. Kanemura, T. Shofuda, M. Onodera, M. Oda, M. Nakamori, T. Nakano, H. Mochizuki (Osaka, Japan)

    Objective: To increase the safety of future cell-based therapy in Parkinson's disease, we generated human induced pluripotent stem cells (hiPSCs) possessing a safety switch via…
  • 2016 International Congress

    Sonographic investigation of Pisa syndrome in Parkinson’s disease

    J. Shiraishi, T. Okazaki, M. Mizuba, K. Kajiwara, S. Saeki, R. Matsugaki, T. Takei, T. Uozumi (Fukuoka, Japan)

    Objective: We hypothesized that the trunk muscles might have an impact on Pisa syndrome, so we performed a sonographic investigation of the trunk muscles of…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley